STOCK TITAN

Evogene Schedules Third Quarter 2025 Financial Results Release

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Evogene (NASDAQ: EVGN) will release its third quarter 2025 financial results on Thursday, November 20, 2025. Company management will host a Zoom conference call the same day at 9:00 AM ET (4:00 PM Israel time) to discuss the results. Investors must register in advance to attend: https://www.veidan-conferencing.com/evogene. The full conference will be available on the company website a few days after the call.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-1.69% News Effect

On the day this news was published, EVGN declined 1.69%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Zoom conference call scheduled for November 20, 2025, 9:00 AM ET

REHOVOT, Israel, Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the third quarter of 2025, on Thursday, November 20, 2025.

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To attend the conference, please register in advance:
https://www.veidan-conferencing.com/evogene

The entire conference will be available online on the company's website a few days after.

About Evogene:

Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries.

At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs.

Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. We call this approach "Real-World Innovation".

Learn more at: www.evogene.com.

Logo: https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg

Contact:
ir@evogene.com
+972-8-9311901

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evogene-schedules-third-quarter-2025-financial-results-release-302607252.html

SOURCE Evogene

FAQ

When will Evogene (EVGN) release its Q3 2025 financial results?

Evogene will release Q3 2025 results on Thursday, November 20, 2025.

What time is the Evogene (EVGN) earnings conference call on November 20, 2025?

The conference call is scheduled for 9:00 AM ET (4:00 PM Israel time) on November 20, 2025.

How can investors register for Evogene's (EVGN) November 20, 2025 call?

Register in advance at https://www.veidan-conferencing.com/evogene to attend the Zoom conference.

Will the Evogene (EVGN) Q3 2025 conference call be available after the live event?

Yes, the company said the entire conference will be available online on its website a few days after the call.

Which time zone is used for Evogene's (EVGN) November 20, 2025 call time?

The company lists the call at 9:00 AM Eastern Time, which is 4:00 PM Israel time.
Evogene

NASDAQ:EVGN

EVGN Rankings

EVGN Latest News

EVGN Latest SEC Filings

EVGN Stock Data

8.98M
8.63M
0.96%
1.61%
1.23%
Biotechnology
Healthcare
Link
Israel
Rehovot